促销时间表 Phoenix Biotech Acquisition Corp.
先进的时间表
简单图表
关于公司
Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. Phoenix Biotech Acquisition Corp. was incorporated in 2021 and is based in Oakland, California.
| Выручка |
0.000255 |
| EBITDA |
-0.000332 |
| Число акций ао |
0.0179 млрд |
| P/S |
719.84 |
| P/BV |
1.33 |
| EV/EBITDA |
-683.3 |
| Цена ао |
4.9 |
| ISIN |
US71902K1051 |
| Сайт |
https://www.phoenixbiotechacquisitioncorp.com
|
| Валюта |
usd |
| IPO date |
2021-11-30 |
| Sector |
Financials |
| Industry |
Capital Markets |
| Валюта отчета |
usd |
| 每日价格变化: |
0% (4.9) |
| 每周价格变化: |
0% (4.9) |
| 每月价格变化: |
0% (4.9) |
| 3个月内价格变化: |
0% (4.9) |
| 六个月内的价格变化: |
0% (4.9) |
| 每年价格变化: |
-54.88% (10.86) |
| 年初以来价格变化: |
-54.92% (10.87) |
|
|
低估
| 姓名 |
意义 |
年级 |
| P/S |
719.84 |
1 |
| P/BV |
74.31 |
1 |
| P/E |
0 |
0 |
| EV/EBITDA |
-31.98 |
0 |
| 全部的: |
|
0.625 |
|
效率
| 姓名 |
意义 |
年级 |
| ROA, % |
-0.6004 |
0 |
| ROE, % |
-0.7706 |
0 |
| 全部的: |
|
0 |
|
|
|
股息
| 姓名 |
意义 |
年级 |
| Div yield, % |
0 |
0 |
| DSI |
0 |
0 |
| 全部的: |
|
0 |
|
责任
| 姓名 |
意义 |
年级 |
| Debt/EBITDA |
-0.114 |
10 |
| 全部的: |
|
10 |
|
成长冲动
| 姓名 |
意义 |
年级 |
| 盈利能力 Revenue, % |
0 |
0 |
| 盈利能力 Ebitda, % |
1629.61 |
10 |
| 盈利能力 EPS, % |
2336.5 |
10 |
| 全部的: |
|
8 |
|
| 导师 |
职称 |
支付 |
出生年份 |
| Mr. Christopher B. Ehrlich M.B.A. |
CEO & Director |
N/A |
1970 (54 年) |
| Dr. Douglas Carl Fisher M.B.A., M.D. |
President |
N/A |
1976 (48 年) |
| Mr. Daniel E. Geffken M.B.A. |
Chief Financial Officer |
N/A |
1957 (67 年) |
